Patents Assigned to Ocularis Pharma, Inc.
  • METHOD AND COMPOSITION WHICH REDUCES STIMULATION OF MUSCLES WHICH DILATE THE EYE
    Publication number: 20060211753
    Abstract: A method for optimizing pupil size in individuals suffering from excessive pupillary dilation in dim light as well as through medication is disclosed. Alpha 1 antagonist is applied in an eye drop formulation to the eye, resulting in reduced pupil size in dim light, but less reduction in pupil size in bright light.
    Type: Application
    Filed: May 1, 2006
    Publication date: September 21, 2006
    Applicant: Ocularis Pharma, Inc.
    Inventor: Gerald Horn
  • Silicone polymer contact lens compositions and methods of use
    Publication number: 20050288196
    Abstract: The present invention is an eye preparation comprising a hydrophobic composition adapted for use on a contact lens inserted into a patient's eye and having a viscosity of 1 to 15,000 centistokes. The composition includes a silicone polymer, fluorinated silicone polymer, fluorocarbon polymer, fluorinated alcohol, or perfluorinated polyether composition, singly or blended, adapted to coat at least a portion of a contact lens inserted in a patient's eye. Silicone polymers for use in the invention include dimethicone, cyclomethicone, and silicone gums.
    Type: Application
    Filed: June 8, 2005
    Publication date: December 29, 2005
    Applicant: Ocularis Pharma, Inc.
    Inventor: Gerald Horn
  • Silicone polymer topical eye compositions and methods of use
    Publication number: 20050288197
    Abstract: The present invention is an eye preparation comprising a hydrophobic composition adapted for use on a patient's eye and having a viscosity of 1 to 15,000 centistokes. The composition includes a silicone polymer, fluorinated silicone polymer, fluorocarbon polymer, fluorinated alcohol, or perfluorinated polyether composition, singly or blended, adapted to coat at least a portion of a patient's eye. Silicone polymers for use in the invention include dimethicone, cyclomethicone, and silicone gums.
    Type: Application
    Filed: June 8, 2005
    Publication date: December 29, 2005
    Applicant: Ocularis Pharma, Inc.
    Inventor: Gerald Horn
  • Night vision composition
    Patent number: 6730065
    Abstract: A method for optimizing pupil size in individuals suffering from excessive pupillary dilation in dim light as well as through medication is disclosed. Alpha 1 antagonist is applied in an eye drop formulation to the eye, resulting in reduced pupil size in dim light, but less reduction in pupil size in bright light.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: May 4, 2004
    Assignee: Ocularis Pharma, Inc.
    Inventor: Gerald Horn